Matthew Abernethy

Matthew Abernethy

Director of Finance/CFO at NEUROCRINE BIOSCIENCES, INC.

Net worth: 4 M $ as of 2024-02-28

44 year
Health Technology
Consumer Services
Commercial Services

Profile

Matthew C. Abernethy is Chief Financial Officer at Neurocrine Biosciences, Inc. and Vice President-Finance of Biomet Orthopedics LLC. He is also on the board of BIOCOM. Mr. Abernethy previously held the position of Treasurer & Vice President-Investor Relations at Zimmer Biomet Holdings, Inc. Treasurer for Biomet, Inc. and Treasurer for Zimmer US, Inc. (both are subsidiaries of Zimmer Biomet Holdings, Inc.). Mr. Abernethy received an undergraduate degree from Grace College & Seminary and an MBA from The University of Chicago.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-12 31,528 ( 0.03% ) 4 M $ 2024-02-28

Matthew Abernethy active positions

CompaniesPositionStart
NEUROCRINE BIOSCIENCES, INC. Director of Finance/CFO 2017-10-31
Director/Board Member 2019-05-28
All active positions of Matthew Abernethy

Former positions of Matthew Abernethy

CompaniesPositionEnd
ZIMMER BIOMET HOLDINGS, INC. Public Communications Contact 2017-10-31
Investor Relations Contact 2017-10-31
Director of Finance/CFO 2015-05-31
Treasurer -
See the detail of Matthew Abernethy's experience

Training of Matthew Abernethy

Grace College & Seminary Undergraduate Degree
The University of Chicago Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew Abernethy's experience

Connections

99

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
NEUROCRINE BIOSCIENCES, INC.

Health Technology

ZIMMER BIOMET HOLDINGS, INC.

Health Technology

Private companies4

Health Technology

Health Technology

Commercial Services

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. Matthew Abernethy